UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000007745 |
|---|---|
| Receipt number | R000009120 |
| Scientific Title | Comparison of between endoscopy by ultra-high magnification endoscope and pathological diagnosis of neoplasms of the esophagus and stomach: a prospective study |
| Date of disclosure of the study information | 2012/04/13 |
| Last modified on | 2015/04/02 09:16:45 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Comparison of between endoscopy by ultra-high magnification endoscope and pathological diagnosis of neoplasms of the esophagus and stomach: a prospective study
Acronym
Comparison of between endoscopy by ultra-high magnification endoscope and pathological diagnosis of neoplasms of the esophagus and stomach
Scientific Title
Comparison of between endoscopy by ultra-high magnification endoscope and pathological diagnosis of neoplasms of the esophagus and stomach: a prospective study
Scientific Title:Acronym
Comparison of between endoscopy by ultra-high magnification endoscope and pathological diagnosis of neoplasms of the esophagus and stomach
Region
| Japan |
Condition
Condition
Esophageal cancer, gastric cancer
Classification by specialty
| Gastroenterology | Gastrointestinal surgery |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
The aim of this study was to investigate the relationship between endoscopy by ultra-high magnification endoscope and pathological diagnosis of neoplasms of the esophagus and stomach.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Differentiation of between endoscopy by ultra-high magnification endoscope and pathological diagnosis of neoplasms of the esophagus and stomach
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Factorial
Randomization
Non-randomized
Randomization unit
Blinding
Open -but assessor(s) are blinded
Control
Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
4
Purpose of intervention
Prevention
Type of intervention
| Device,equipment | Maneuver |
Interventions/Control_1
NBI findings, benign; pathological diagnosis, benign
Interventions/Control_2
NBI findings, malignancy; pathological diagnosis, benign
Interventions/Control_3
NBI findings, benign; pathological diagnosis, malignancy
Interventions/Control_4
NBI findings, malignancy; pathological diagnosis, malignancy
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 85 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
(1) age 20-85 years
Key exclusion criteria
(1) Any patients judged to be unfit to participate in the study, by the investigator
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Haruhiro Inoue, MD, PhD |
Organization
Showa University Koto Toyosu Hospital
Division name
Digestive Disease Center
Zip code
Address
5-1-38 Toyosu, Koto-ku, Tokyo 135-8577, Japan
TEL
03-6204-6000
haruinoue777@yahoo.co.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Haruhiro Inoue, MD, PhD |
Organization
Showa University Koto Toyosu Hospital
Division name
Digestive Disease Center
Zip code
Address
5-1-38 Toyosu, Koto-ku, Tokyo 135-8577, Japan
TEL
03-6204-6000
Homepage URL
haruinoue777@yahoo.co.jp
Sponsor or person
Institute
Digestive Disease Center, Showa University Koto Toyosu Hospital
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Outside Japan
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2012 | Year | 04 | Month | 13 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2012 | Year | 04 | Month | 12 | Day |
Date of IRB
Anticipated trial start date
| 2012 | Year | 04 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2012 | Year | 04 | Month | 13 | Day |
Last modified on
| 2015 | Year | 04 | Month | 02 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009120
